M28 Capital Management as of June 30, 2023
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 12 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 33.9 | $26M | 7.1M | 3.64 | |
| Rocket Pharmaceuticals (RCKT) | 16.6 | $13M | 630k | 19.87 | |
| Adagio Therapeutics (IVVD) | 12.8 | $9.7M | 9.2M | 1.05 | |
| Springworks Therapeutics (SWTX) | 6.8 | $5.2M | 198k | 26.22 | |
| Curis Com New | 6.6 | $5.0M | 6.0M | 0.83 | |
| Stoke Therapeutics (STOK) | 4.9 | $3.7M | 346k | 10.63 | |
| Tg Therapeutics (TGTX) | 4.7 | $3.5M | 143k | 24.84 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 4.1 | $3.1M | 1.9M | 1.62 | |
| Bridgebio Pharma (BBIO) | 3.8 | $2.9M | 166k | 17.20 | |
| Arrowhead Pharmaceuticals (ARWR) | 3.2 | $2.4M | 67k | 35.66 | |
| Silence Therapeutics Ads (SLN) | 2.6 | $2.0M | 364k | 5.50 | |
| Neximmune | 0.0 | $38k | 133k | 0.28 |
